iTeos Therapeutics, Inc. (ITOS) Tops Q2 EPS by 86c
Tweet
Share
E-mailGet Alerts ITOS Hot Sheet
Join SI Premium – FREE
iTeos Therapeutics, Inc. (NASDAQ: ITOS) reported Q2 EPS of ($0.18), $0.86 better than the analyst estimate of ($1.04).
For earnings history and earnings-related data on iTeos Therapeutics, Inc. (ITOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Morgan Stanley sees limited gas regulation impact on utilities
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
